Table 1 Baseline patient characteristics

From: Efficiency of coordinator-based osteoporosis intervention in fragility fracture patients: a prospective randomized trial

  LI (n = 70) Non-LI (n = 71) p values
Age (years) 76.3 ± 8.6 76.5 ± 7.8 0.876
Sex (n/%)
Men 12 (17.1) 11 (15.5) 0.791
Women 58 (82.9) 60 (84.5) 0.791
Past fragility fracture (n/%) 21 (30.0) 22 (31.0) 0.811
History (n/%)
Hypertension 31 (44.3) 32 (45.1) 0.986
Diabetes 9 (12.9) 10 (14.1) 0.832
Cerebral infarction sequelae 4 (5.7) 2 (2.8) 0.393
Heart disease 10 (14.3) 13 (18.3) 0.517
Rheumatoid arthritis 3 (4.3) 3 (4.2) 0.985
Hyperthyroidism 1 (1.4) 0 (0.0) 0.312
Other disease 14 (20.0) 21 (29.6) 0.186
Fracture sites (n/%)
Hip 9 (12.9) 9 (12.7) 0.974
Vertebral body 46 (65.7) 47 (66.2) 0.952
Distal radius/proximal humerus 9 (12.9) 10 (14.1) 0.831
Other sites 6 (8.6) 5 (7.0) 0.735
  1. LI, coordinator intervention group; non-LI, without intervention group. Data were analyzed using chi-squared test or Fisher’s exact test (p < 0.05)